Procyon Advisors LLC lessened its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,950 shares of the medical research company’s stock after selling 673 shares during the quarter. Procyon Advisors LLC’s holdings in Thermo Fisher Scientific were worth $5,281,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in TMO. Planned Solutions Inc. acquired a new stake in shares of Thermo Fisher Scientific in the 4th quarter valued at $301,000. Jacobs & Co. CA increased its holdings in shares of Thermo Fisher Scientific by 21.0% during the fourth quarter. Jacobs & Co. CA now owns 14,166 shares of the medical research company’s stock worth $7,519,000 after buying an additional 2,460 shares in the last quarter. Sterling Investment Management LLC raised its holdings in shares of Thermo Fisher Scientific by 35.2% in the fourth quarter. Sterling Investment Management LLC now owns 6,281 shares of the medical research company’s stock valued at $3,334,000 after buying an additional 1,634 shares during the last quarter. IFG Advisory LLC acquired a new position in Thermo Fisher Scientific during the 4th quarter worth about $220,000. Finally, Columbia Trust Co 01012016 boosted its position in Thermo Fisher Scientific by 20.8% in the 4th quarter. Columbia Trust Co 01012016 now owns 4,072 shares of the medical research company’s stock valued at $2,161,000 after buying an additional 701 shares during the last quarter. Institutional investors and hedge funds own 89.23% of the company’s stock.
Insider Buying and Selling at Thermo Fisher Scientific
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 10,000 shares of the business’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $597.98, for a total value of $5,979,800.00. Following the transaction, the chief executive officer now directly owns 123,816 shares in the company, valued at $74,039,491.68. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Marc N. Casper sold 5,547 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $550.62, for a total value of $3,054,289.14. Following the sale, the chief executive officer now owns 43,608 shares of the company’s stock, valued at $24,011,436.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Marc N. Casper sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $597.98, for a total transaction of $5,979,800.00. Following the completion of the transaction, the chief executive officer now directly owns 123,816 shares of the company’s stock, valued at $74,039,491.68. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,277 shares of company stock worth $28,513,384. Insiders own 0.32% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Stock Report on Thermo Fisher Scientific
Thermo Fisher Scientific Price Performance
TMO stock traded up $1.87 during trading on Thursday, reaching $581.24. 125,336 shares of the company were exchanged, compared to its average volume of 1,602,185. The company has a 50-day moving average of $564.32 and a two-hundred day moving average of $519.80. The company has a market capitalization of $221.63 billion, a price-to-earnings ratio of 37.50, a P/E/G ratio of 2.39 and a beta of 0.80. Thermo Fisher Scientific Inc. has a twelve month low of $415.60 and a twelve month high of $603.82. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.75 and a quick ratio of 1.39.
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) last posted its earnings results on Wednesday, January 31st. The medical research company reported $5.67 EPS for the quarter, beating the consensus estimate of $5.64 by $0.03. Thermo Fisher Scientific had a return on equity of 18.78% and a net margin of 13.99%. The firm had revenue of $10.89 billion during the quarter, compared to the consensus estimate of $10.73 billion. During the same period last year, the company earned $5.40 earnings per share. The business’s quarterly revenue was down 4.9% on a year-over-year basis. As a group, equities analysts predict that Thermo Fisher Scientific Inc. will post 21.52 earnings per share for the current fiscal year.
Thermo Fisher Scientific Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Investors of record on Friday, March 15th will be issued a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date is Thursday, March 14th. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.35. Thermo Fisher Scientific’s dividend payout ratio is currently 10.10%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Recommended Stories
- Five stocks we like better than Thermo Fisher Scientific
- What is a Secondary Public Offering? What Investors Need to Know
- Disney Stock Catches 3 Upgrades In a Single Week
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
- What Does a Stock Split Mean?
- Delta Airline’s Put Option Activity Isn’t Bad News
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.